ONCR

Oncorus Inc.

Price

return (12m)

p/e

-0.03

p/bv

0.11

DIVIDEND YIELD

0.00%

ONCR price

Oncorus

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ONCR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ONCR

Valuation

P/E

-0.03

Sector -4.38

Industry -4.38

P/BV

0.11

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector -4.40

Industry -4.40

EV/EBITDA

Sector -263.09

Industry -263.09

EV/EBIT

Sector -702.90

Industry -702.90

P/EBITDA

-0.03

Sector -4.39

Industry -4.39

P/EBIT

-0.03

Sector -4.73

Industry -4.73

P/Total Assets

0.03

Sector 1.49

Industry 1.49

P/Net Current Assets

Sector -11.70

Industry -11.70

P/Working Capital

Sector -3.19

Industry -3.19

EPS

-4.88

Sector -2.14

Industry -2.14

BVPS

1.19

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

0.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

0.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

0.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-409.41%

Sector -65.14%

Industry -65.14%

ROA

-116.09%

Sector -65.53%

Industry -65.53%

ROIC

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 2.90

Industry 2.90

Net Debt / EBITDA

Sector -6.07

Industry -6.07

Net Debt / EBIT

Sector -8.26

Industry -8.26

Net Debt / Equity

Sector -1.07

Industry -1.07

Gross Debt / Equity

Sector -0.05

Industry -0.05

Equity/Assets

0.28

Sector 0.41

Industry 0.41

Liabilities/Assets

0.28

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

14.49%

Sector -

Industry -

Fundamentals ONCR

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ONCR Oncorus Inc.	$0.00	-	0.00%	-0.03	0.11	-409.41%	0.00%
JNJ Johnson & Johnson	$271.64	57.43%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.08	20.74%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.33	32.79%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.31	-9.49%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$151.02	84.93%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$165.36	5.18%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$66.51	44.10%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.43	-49.79%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$836.36	42.29%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$434.98	52.52%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$106.49	52.17%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$846.67	25.72%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$544.90	39.45%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$230.89	56.92%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$38.49	5.74%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$218.15	57.10%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ONCR Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Oncorus

Oncorus Inc.

Average Investor10 user rating

4.0 (0 people)

United States

11 years

Founded: 2015

2020

Time since IPO - 6 years

56

Employees

Oncorus Inc. (United States) is listed on the Nasdaq and has a market capitalization of $3.29 million, with shareholders equity totaling $31.12 million.

The company employs approximately 56 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Oncorus Inc. reported $- in revenue, generating net income of $-127.41 million.

Key financial metrics include a P/E ratio of -0.03, a price-to-book (P/B) ratio of 0.11, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ONCR.

Market cap

$3.29 million

Net worth

$31.12 million

$31,121,000.00

Assets

$109.75 million

$109,753,000.00

Total Shares Outstanding

26.10 million

26,095,000

Average Daily Trading Volume

Sector

Health Care

Industry

Biotechnology

ONCR

ONCR revenue and profits

Financial Results ONCR

DRAG THE FRAME TO SEE MORE DATA

ONCR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$846.67 21,06% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$230.89 52,88% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$271.64 56,52% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.33 30,91% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$151.02 85,52% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$165.36 5,26% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.08 20,45% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$846.67 21,06% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$230.89 52,88% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$271.64 56,52% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.33 30,91% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$151.02 85,52% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$165.36 5,26% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.08 20,45% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Oncorus (ONCR) today?

A cotação de Oncorus (ONCR) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de Oncorus (ONCR) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Oncorus (ONCR) e dados de ações do Ibovespa e mercados internacionais.

Quando Oncorus (ONCR) paga dividendos?

Oncorus (ONCR) não distribuiu dividendos no último ano.

Is Oncorus (ONCR) a good investment?

Atualmente, Oncorus (ONCR) está cotada a US$ 0.00, com um P/L de -0.03, representando um desvio de -5% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Oncorus (ONCR) stock?

Investir em ações de Oncorus (ONCR) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Oncorus (ONCR) yield today?

A rentabilidade de Oncorus (ONCR) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Oncorus (ONCR) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ONCR

Oncorus Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ONCR

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING ONCR WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Oncorus

Oncorus Inc.

United States

11 years

2020

56

PROFIT X PRICE ONCR

Financial Results ONCR

ONCR cash flow

Asset, Revenue and Profit Growth - ONCR

ONCR balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions